APA (7th ed.) Citation

C, A., LT, B., CT, F., S, H., H, K., L, H., . . . M, R. (2020). Spironolactone reduces biochemical markers of bone turnover in postmenopausal women with primary aldosteronism. Endocrine, 69(3), 625. https://doi.org/10.1007/s12020-020-02348-8

Chicago Style (17th ed.) Citation

C, Adolf, et al. "Spironolactone Reduces Biochemical Markers of Bone Turnover in Postmenopausal Women with Primary Aldosteronism." Endocrine 69, no. 3 (2020): 625. https://doi.org/10.1007/s12020-020-02348-8.

MLA (9th ed.) Citation

C, Adolf, et al. "Spironolactone Reduces Biochemical Markers of Bone Turnover in Postmenopausal Women with Primary Aldosteronism." Endocrine, vol. 69, no. 3, 2020, p. 625, https://doi.org/10.1007/s12020-020-02348-8.